Effect of GLP-1 on microvascular function in patients with type 2 diabetes.

Trial Profile

Effect of GLP-1 on microvascular function in patients with type 2 diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2014

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms EGOFIP
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Sep 2013 New source identified and integrated: ClinicalTrials.gov record.
    • 26 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top